The combined effect creates a metabolic state where appetite is significantly reduced, gastric emptying is slowed (meaning food stays in the stomach longer and meals feel more satisfying), insulin dynamics are optimized for fat mobilization rather than fat storage, and resting energy expenditure is elevated through glucagon-mediated thermogenesis
Subcellular distribution of enzymes of glutamate metabolism in rat brain
Ipamorelin offers a targeted, low-risk method of stimulating your bodys natural growth hormone releasewithout the cortisol spikes or prolactin elevation seen in older GHRPs
Retatrutide works by enhancing insulin secretion, suppressing appetite, slowing gastric emptying, and improving energy metabolism
Key takeaways: GLP-1 medications are primarily used for weight loss, but are increasingly being explored in relation to PCOS and perimenopause Early evidence (mainly in women with obesity and PCOS) suggests GLP-1s may improve insulin resistance and support more regular menstrual cycles and ovulation There is currently limited research on how GLP-1 medications affect periods, fertility, PMS, or menopause symptoms in the wider population Period tracking apps like Clue may help users monitor cycle and symptom changes while using GLP-1 medications 1
Plus, research shows they can help prevent heart problems, lower the risk of worsening kidney disease, and aid sleep apnea all health issues that can become more common with age